Disease relevance of Panniculitis, Peritoneal

• Because most mesenteric fibromatoses have mutations in the pathway and hence have abnormal nuclear accumulation of beta-catenin protein, we studied beta-catenin expression among a panel of other immunohistochemical stains to distinguish mesenteric fibromatosis, GIST, and sclerosing mesenteritis [1].
• Immunomodulation with prednisone led to a rapid and complete remission of the proteinuria but did not alter the course of the underlying sclerosing mesenteritis [2].

High impact information on Panniculitis, Peritoneal

• Successful treatment of retractile mesenteritis with oral progesterone [3].
• Successful treatment of a patient with retractile mesenteritis with prednisone and azathioprine [4].
• Sclerosing mesenteritis. Response to cyclophosphamide [5].
• Two of five sclerosing mesenteritis cases focally expressed CD117 [1].
• None of the sclerosing mesenteritis cases had nuclear beta-catenin [1].

Chemical compound and disease context of Panniculitis, Peritoneal

• CONCLUSIONS: Thalidomide is safe, well tolerated and efficacious in the treatment of some patients with symptomatic mesenteric panniculitis [6].
• We present the first case of sclerosing mesenteritis to respond to tamoxifen therapy [7].
• Cholesterol ester storage disease and mesenteric lipodystrophy [8].
• Successful steroid therapy for postoperative mesenteric panniculitis [9].
• Fibrosing omental panniculitis and polyserositis associated with long-term treatment by paroxetine [10].

Gene context of Panniculitis, Peritoneal

• F-18 FDG PET demonstration of sclerosing mesenteritis [11].

Analytical, diagnostic and therapeutic context of Panniculitis, Peritoneal

• The author presents an additional case of sclerosing mesenteritis demonstrated on fluorine-18 fluorodeoxyglucose positron emission tomography with multidetector computed tomographic correlation [11].

References